Lv3
258 积分 2022-01-04 加入
HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer
1天前
已完结
Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-dependent CKD Patients
3个月前
已完结
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
5个月前
已完结
皖公网安备34019202002308
